Paper42579041
Association of implementation of secondary fracture prevention incentives after hip fracture and risk of subsequent fracture in real-world practice.
Hiyama Y and 1 other. Eur Geriatr Med, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Association of implementation of secondary fracture prevention incentives after hip fracture and risk of subsequent fracture in real-world practice. Papers, record 42579041. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42579041
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Association of implementation of secondary fracture prevention incentives after hip fracture and risk of subsequent fracture in real-world practice.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References40
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 36374576 | What was the Epidemiology and Global Burden of Disease of Hip Fractures From 1990 to 2019? Results From and Additional Analysis of the Global Burden of Disease Study 2019. | Clin Orthop Relat Res | 2023 | https://conductscience.org/library/papers/36374576 | PubMed |
| 2 | 37118993 | Global Epidemiology of Hip Fractures: Secular Trends in Incidence Rate, Post-Fracture Treatment, and All-Cause Mortality. | J Bone Miner Res | 2023 | https://conductscience.org/library/papers/37118993 | PubMed |
| 3 | 35364728 | Incidence of different types of subsequent fractures and related mortality in Taiwan. | Arch Osteoporos | 2022 | https://conductscience.org/library/papers/35364728 | PubMed |
| 4 | 30864015 | Short-term risk factors for a second hip fracture in a UK population. | Eur J Orthop Surg Traumatol | 2019 | https://conductscience.org/library/papers/30864015 | PubMed |
| 5 | 35441744 | Incidence of Subsequent Hip Fracture and Mortality in Elderly Patients: A Multistate Population-Based Cohort Study in Eastern Spain. | J Bone Miner Res | 2022 | https://conductscience.org/library/papers/35441744 | PubMed |
| 6 | 32659601 | The impact of second hip fracture on rehospitalization and mortality in older adults. | Arch Gerontol Geriatr | 2020 | https://conductscience.org/library/papers/32659601 | PubMed |
| 7 | 38536447 | Effectiveness of fracture liaison service in reducing the risk of secondary fragility fractures in adults aged 50 and older: a systematic review and meta-analysis. | Osteoporos Int | 2024 | https://conductscience.org/library/papers/38536447 | PubMed |
| 8 | 33829285 | The impact of fracture liaison services on subsequent fractures and mortality: a systematic literature review and meta-analysis. | Osteoporos Int | 2021 | https://conductscience.org/library/papers/33829285 | PubMed |
| 9 | 33522384 | Physical Therapy Management of Older Adults With Hip Fracture. | J Orthop Sports Phys Ther | 2021 | https://conductscience.org/library/papers/33522384 | PubMed |
| 10 | 38952014 | Zoledronic acid for hip fracture during initial hospitalization. | J Bone Miner Res | 2024 | https://conductscience.org/library/papers/38952014 | PubMed |
| 11 | 39808195 | Fracture liaison service (FLS) is associated with lower subsequent fragility fracture risk and mortality: NoFRACT (the Norwegian capture the fracture initiative). | Osteoporos Int | 2025 | https://conductscience.org/library/papers/39808195 | PubMed |
| 12 | 36205166 | Anti-osteoporotic treatment after hip fracture remains alarmingly low. | Dan Med J | 2022 | https://conductscience.org/library/papers/36205166 | PubMed |
| 13 | 30646034 | Association of Osteoporosis Medication Use After Hip Fracture With Prevention of Subsequent Nonvertebral Fractures: An Instrumental Variable Analysis. | JAMA Netw Open | 2018 | https://conductscience.org/library/papers/30646034 | PubMed |
| 14 | 40592642 | Current status of patients with hip fracture in Japan: A nationwide survey. | J Orthop Sci | 2026 | https://conductscience.org/library/papers/40592642 | PubMed |
| 15 | 41091162 | Impact of a national reimbursement policy on anti-osteoporosis medication prescription at discharge after hip-fracture surgery in Japan: an interrupted time-series analysis. | Osteoporos Int | 2025 | https://conductscience.org/library/papers/41091162 | PubMed |
| 16 | 39671048 | Impact of the guidance on fracture Liaison Services and the introduction of a new fee for secondary fracture prevention in Japan: Implementation of secondary fracture prevention during hospitalization for fragility fractures. | Osteoporos Int | 2025 | https://conductscience.org/library/papers/39671048 | PubMed |
| 17 | 40226165 | DeSC database. | Ann Clin Epidemiol | 2025 | https://conductscience.org/library/papers/40226165 | PubMed |
| 18 | 20234789 | Hip fracture incidence in Japan: estimates of new patients in 2007 and 20-year trends. | Arch Osteoporos | 2009 | https://conductscience.org/library/papers/20234789 | PubMed |
| 19 | 40938461 | Temporal trends in acute care costs of hip fracture treatment from 2011 to 2021 in Japan. | Arch Osteoporos | 2025 | https://conductscience.org/library/papers/40938461 | PubMed |
| 20 | 38988134 | Following hip fracture, hospital organizational factors associated with prescription of anti-osteoporosis medication on discharge, to address imminent refracture risk: a record-linkage study. | J Bone Miner Res | 2024 | https://conductscience.org/library/papers/38988134 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42579041
GET https://conductscience.org/api/papers/v1/42579041/references?page=2